People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gliknik Inc | — | Biotechnology | Series A | $50.7M | $33.6M | 2023 |
| Cocrystal Pharma, Inc. | — | Pharmaceuticals | Series A | $28.9M | $92.9M | 2016 |
| Centrose LLC | — | Pharmaceuticals | Series B | $5.2M | $3.4M | 2013 |
| RFS Pharma, LLC | — | Biotechnology | Series A | $5.0M | $180.8M | 2014 |
Raymond F. Schinazi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Raymond F. Schinazi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Raymond S. Schinazi | 2 | 2 |
| David S. Block | 2 | 2 |
| Steven D. Rubin | 1 | 9 |
| TROY WILSON | 1 | 7 |
| Steven Rubin | 1 | 7 |
| JANE H HSIAO | 1 | 5 |
| Sam Lee | 1 | 5 |
| Richard Lerner | 1 | 5 |
| Richard Levy | 1 | 4 |
| Richard S. Levy | 1 | 4 |
| Roger Kornberg | 1 | 4 |
| Gary Wilcox | 1 | 4 |
| David Broser | 1 | 3 |
| JEFFREY A MECKLER | 1 | 3 |
| Jane Hsiao | 1 | 3 |
| Phillip Frost | 1 | 3 |
| Paul A. Friedman | 1 | 2 |
| Charles Polsky | 1 | 2 |
| Geeta A. Vemuri | 1 | 1 |
| Geeta S. Vemuri | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.